<DOC>
	<DOCNO>NCT00503386</DOCNO>
	<brief_summary>The purpose study determine whether palonosetron tolerate effective prevent chemotherapy-induced nausea vomit oriental population . The study compare safety efficacy palonosetron granisetron , frequently use antiemetic China .</brief_summary>
	<brief_title>Safety Efficacy Palonosetron Preventing Chemotherapy-induced Nausea Vomiting</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Palonosetron</mesh_term>
	<mesh_term>Granisetron</mesh_term>
	<criteria>Male female , age ≥ 18 yr ＜70 yr histologically cytologically confirm Malignant disease Naive nonnaive chemotherapy , Karnofsky score ≥ 60 Scheduled receive two course moderately emetogenic chemotherapy cisplatin 60 ~ 80 mg/m2 study Day 1 Use reliable contraceptive measure ( female childbearing potential ) negative pregnancy test baseline visit Patients hepatic , renal , cardiovascular impairment eligible investigator 's discretion Patients experience , maximum , mild nausea previous chemotherapy eligible investigator 's discretion Predicted life expectancy ≥ 3 month Provision write informed consent . Inability understand cooperate study procedure Receipt investigational drug ≤ 30 day study entry Receipt investigational drug course study Seizure disorder condition require anticonvulsant , sedative CNS malignancy metastasis Ongoing emesis due obstruction digestive tract Emesis , retch , Grade 2 3 nausea 24 hr chemotherapy Moderate severe nausea vomit previous chemotherapy Scheduled receipt chemotherapeutic agent emetogenicity level ＞3 study Days 25 Scheduled receipt radiotherapy upper abdomen cranium study Days 25 Scheduled receive drug potential antiemetic efficacy within 24 h study initiation throughout day 5 Contraindications 5HT3 receptor antagonist Contraindications chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>chemotherapy-induced nausea vomit</keyword>
	<keyword>acute</keyword>
	<keyword>delayed</keyword>
	<keyword>emesis</keyword>
	<keyword>antiemetic</keyword>
	<keyword>5-HT3 receptor antagonist</keyword>
	<keyword>granisetron</keyword>
	<keyword>palonosetron</keyword>
</DOC>